ITeos Therapeutics Current Cash

ITeos Therapeutics (ITOS) currently reports a current cash of $210M as of June 2025. That compares with $250M in the prior-year period — down 17.2% year over year. Use the charts on this page to explore ITeos Therapeutics's current cash history and peer comparisons.

ITeos Therapeutics's current cash decreased from $250M to $210M — a 17.2% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ITeos Therapeutics reported $210M in current cash as of June 2025. That compares with $250M in the prior-year period — down 17.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ITeos Therapeutics, and consider following ITOS for alerts when major investors trade the stock.

ITeos Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITOS with unrelated industries.